Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024777 · ClinicalTrials.gov registry record · Phase 1
Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01024777: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT01024777 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01024777, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and the immunologic effects of supplementation with low-dose and high-dose cholecalciferol (vitamin D3) in patients with multiple sclerosis.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01024777
The ClinicalTrials.gov registry entry for NCT01024777 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT01024777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01024777 about?
NCT01024777 is a clinical study titled "Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis". The purpose of this study is to determine the safety and the immunologic effects of supplementation with low-dose and high-dose cholecalciferol (vitamin D3) in patients with multiple sclerosis.
What is the current status of trial NCT01024777?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2010-03. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01024777?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01024777?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.